Phio Pharmaceuticals Corp... (PHIO)

NASDAQ: PHIO · Real-Time Price · USD

1.95

0.06 (3.17%)

At close: May 02, 2025, 1:45 PM

Phio Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	21K	138K	15K	19K
Cost of Revenue	n/a	6.33M	193K	192K	183K	4.3K	4.33M	5.37M	5.42M
Gross Profit	n/a	-6.33M	-193K	-192K	-183K	16.7K	-4.19M	-5.36M	-5.4M
Operating Income	-7.39M	-10.82M	-11.46M	-13.51M	-8.79M	-8.99M	-7.36M	-14.06M	-9.02M
Interest Income	n/a	n/a	n/a	n/a	1.00	n/a	n/a	n/a	n/a
Pretax Income	-7.15M	-10.83M	-11.48M	-13.29M	-8.79M	-8.91M	-7.36M	-14.07M	-8.99M
Net Income	-7.15M	-10.83M	-11.3M	-13.21M	-8.79M	-8.84M	-7.36M	-12.45M	-8.99M
Selling & General & Admin	3.74M	4.29M	4.45M	4.63M	4.36M	4.71M	3.18M	4.01M	3.62M
Research & Development	3.64M	6.33M	7.01M	8.89M	4.43M	4.3M	4.33M	5.37M	5.42M
Other Expenses	n/a	-6.13M	-18K	224K	-1K	79K	4K	4.7M	3.11M
Operating Expenses	7.39M	4.49M	11.46M	13.51M	8.79M	9.01M	7.5M	9.38M	9.03M
Interest Expense	231K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	10.82M	11.46M	13.51M	8.79M	9.01M	7.5M	9.38M	9.03M
Income Tax Expense	n/a	n/a	-175K	-75K	-134.3K	-67K	4K	-1.62M	-74K
Shares Outstanding (Basic)	7.87M	231K	126.16K	118.68K	42.43K	4.26K	1.18K	379.62	113.44
Shares Outstanding (Diluted)	7.87M	231.51K	126.16K	118.68K	42.43K	4.26K	1.18K	379.62	113.44
EPS (Basic)	-0.91	-46.87	-89.61	-111.32	-207.25	-2.07K	-6.22K	-32.8K	-79.28K
EPS (Diluted)	-0.91	-46.76	-89.61	-111.32	-207.25	-2.07K	-6.22K	-32.8K	-79.28K
EBITDA	-7.12M	-10.64M	-11.29M	-13.09M	-8.72M	-8.92M	-7.28M	-14M	-8.96M
EBIT	-6.92M	-10.83M	-11.48M	-13.51M	-8.79M	-8.99M	-7.36M	-14.07M	-9.02M
Depreciation & Amortization	n/a	184K	193K	192K	183K	67K	81K	70K	53K